StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
218
This month
2
This week
1
This year
32
Publishing Date
2024 - 03 - 13
2
2024 - 02 - 22
2
2024 - 02 - 12
2
2024 - 01 - 30
2
2024 - 01 - 17
2
2023 - 12 - 12
2
2023 - 11 - 28
2
2023 - 09 - 22
2
2023 - 08 - 25
2
2023 - 08 - 09
2
2023 - 07 - 26
2
2023 - 05 - 10
2
2023 - 04 - 13
3
2023 - 04 - 12
3
2023 - 03 - 10
2
2023 - 02 - 22
3
2023 - 02 - 17
2
2023 - 02 - 13
2
2023 - 02 - 08
2
2023 - 02 - 02
2
2022 - 12 - 08
2
2022 - 09 - 29
2
2022 - 09 - 27
2
2022 - 09 - 26
2
2022 - 09 - 19
2
2022 - 09 - 02
2
2022 - 08 - 17
2
2022 - 08 - 03
2
2022 - 07 - 25
2
2022 - 06 - 24
2
2022 - 06 - 17
2
2022 - 05 - 17
2
2022 - 05 - 11
2
2022 - 04 - 21
1
2022 - 04 - 13
1
2022 - 04 - 12
2
2022 - 03 - 22
1
2022 - 03 - 16
1
2022 - 03 - 11
1
2022 - 03 - 10
1
2022 - 03 - 08
1
2022 - 03 - 07
1
2022 - 03 - 01
1
2022 - 02 - 28
1
2022 - 02 - 23
1
2022 - 02 - 22
1
2022 - 02 - 21
1
2022 - 01 - 21
1
2021 - 12 - 24
1
2021 - 12 - 16
1
2021 - 12 - 14
1
2021 - 12 - 06
1
2021 - 11 - 12
1
2021 - 11 - 10
1
2021 - 11 - 04
1
2021 - 10 - 18
1
2021 - 10 - 07
1
2021 - 10 - 06
1
2021 - 10 - 04
1
2021 - 09 - 28
1
Sector
Commercial services
1
Consumer non-durables
1
Electronic technology
1
Health care and social assistance
1
Health technology
218
Information
1
Manufacturing
51
Mining, quarrying, and oil and gas extraction
1
N/a
25
Process industries
4
Producer manufacturing
4
Professional, scientific, and technical services
3
Retail trade
1
Technology services
2
Tags
Abbvie
7
Active
2
Acute myeloid leukemia
2
Advanced
2
Alzheimer's
7
Alzheimer’s
2
America
23
Aml
2
Antibacterial
2
Antibody
4
Antiviral
2
Approval
3
Asia
3
Biomarkers
2
Breast
3
Business
3
Cancer
13
Cel
2
Cell
2
Cystic fibrosis
2
Dementia
3
Dermatitis
3
Dermatological
3
Disease
18
Drug
18
Europe
3
Expansion
2
Expected
9
Eye
6
Fibrosis
2
Financial
4
Glaucoma
3
Global
50
Growing
10
Growth
76
Health
7
Hypertension
2
Infection
3
Key
2
Leukemia
4
Liver
2
Lung
2
Market
174
Myeloid leukemia
2
N/a
218
Novartis
5
Parkinson's
2
Pharma
5
Pharmaceuticals
4
Pipeline
4
Rare
3
Reach
6
Report
40
Research
25
Results
5
Set
8
T-cell
3
Therapeutics
49
Therapy
11
Treatment
21
Entities
3m company
8
Abbott laboratories
105
Abbvie inc.
218
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
12
Alcon inc.
14
Alkermes plc
7
Amgen inc.
168
Astellas pharma inc
70
Astrazeneca plc
171
Autolus therapeutics plc
7
Bausch health companies inc.
61
Baxter international inc.
45
Becton, dickinson and company
17
Beigene, ltd.
7
Biogen inc.
47
Biomarin pharmaceutical inc.
6
Biontech se
9
Boston scientific corporation
13
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
82
Chinook therapeutics, inc.
7
Csl ltd
9
Danaher corporation
10
Eli lilly and company
121
Endo international plc
20
General electric company
8
Genmab a/s
12
Gilead sciences, inc.
25
Glaxosmithkline plc
264
Grifols sa
10
Incyte corporation
15
Ionis pharmaceuticals, inc.
7
Jazz pharmaceuticals plc
13
Johnson & johnson
189
Koninklijke philips n.v.
17
Mallinckrodt plc
17
Medtronic plc
29
Morphosys ag
12
Novartis ag
1031
Novo nordisk a/s
27
Orange
8
Orchard therapeutics plc
8
Perrigo company
7
Pfizer, inc.
68
Precision biosciences, inc.
8
Reckitt benckiser group plc
9
Regeneron pharmaceuticals, inc.
12
Regenxbio inc.
11
Sanofi
284
Smith & nephew plc
7
Stryker corporation
10
Takeda pharmaceutical company limited
51
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
48
Ucb s.a.
8
Viatris inc.
115
Xencor, inc.
9
Symbols
ABBV
1024
ABT
61
ADCT
9
AGIO
12
ALC
15
ALNY
12
ALPMF
49
ALPMY
49
AMGN
165
ANIK
10
AVEO
10
AZN
100
AZNCF
90
BAX
28
BCRX
13
BGNE
11
BHC
58
BIIB
37
BMY
88
BPMC
11
BSX
9
CHRS
38
CLVS
10
ENDP
11
EPZM
10
EXEL
11
GIFLF
10
GIKLY
10
GILD
41
GLAXF
139
GMAB
30
GNMSF
26
GSK
155
ILMN
11
INCY
17
IRWD
13
JNJ
162
KPTI
13
LLY
111
MDT
20
NVO
14
NVS
239
NVSEF
218
OMER
13
OTIC
13
PFE
37
REGN
23
RIGL
10
SNY
211
SNYNF
167
TAK
31
TEVA
10
TEVJF
129
TMO
33
UCBJF
14
UCBJY
14
VSTM
10
VTRS
68
XERS
11
YMAB
10
Exchanges
Amex
1
Nasdaq
218
Nyse
218
Crawled Date
2024 - 03 - 13
2
2024 - 02 - 22
2
2024 - 02 - 12
2
2024 - 02 - 07
2
2024 - 01 - 30
2
2024 - 01 - 17
2
2023 - 12 - 12
2
2023 - 11 - 28
2
2023 - 09 - 22
2
2023 - 08 - 31
2
2023 - 08 - 25
2
2023 - 08 - 09
2
2023 - 07 - 26
2
2023 - 05 - 10
2
2023 - 04 - 13
3
2023 - 04 - 12
3
2023 - 03 - 10
2
2023 - 02 - 22
3
2023 - 02 - 17
2
2023 - 02 - 02
2
2022 - 12 - 15
2
2022 - 09 - 27
2
2022 - 09 - 26
2
2022 - 09 - 19
2
2022 - 09 - 02
2
2022 - 08 - 17
2
2022 - 08 - 03
2
2022 - 07 - 25
2
2022 - 06 - 24
2
2022 - 06 - 17
2
2022 - 05 - 17
2
2022 - 05 - 11
2
2022 - 04 - 25
1
2022 - 04 - 21
1
2022 - 04 - 13
1
2022 - 04 - 12
2
2022 - 03 - 22
1
2022 - 03 - 16
1
2022 - 03 - 11
1
2022 - 03 - 10
1
2022 - 03 - 08
1
2022 - 03 - 07
1
2022 - 03 - 02
1
2022 - 02 - 28
1
2022 - 02 - 23
1
2022 - 02 - 22
1
2022 - 02 - 21
1
2022 - 01 - 21
1
2021 - 12 - 24
1
2021 - 12 - 16
1
2021 - 12 - 14
1
2021 - 12 - 06
1
2021 - 11 - 12
1
2021 - 11 - 10
1
2021 - 11 - 04
1
2021 - 10 - 18
1
2021 - 10 - 07
1
2021 - 10 - 06
1
2021 - 10 - 04
1
2021 - 09 - 28
1
Crawled Time
00:00
15
01:00
14
02:00
7
03:00
7
04:00
8
04:20
1
05:00
7
06:00
6
07:00
5
08:00
9
09:00
12
10:00
6
11:00
12
12:00
8
12:20
1
13:00
1
13:20
2
13:30
2
14:00
5
14:20
1
14:30
1
15:00
4
15:20
3
15:30
3
16:00
12
17:00
8
18:00
12
19:00
6
20:00
11
21:00
5
22:00
11
23:00
13
Source
www.globenewswire.com
8
www.prnewswire.com
210
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Abbvie inc.
symbols :
NVSEF
save search
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published:
2024-04-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-1.75%
H:
0.85%
C:
0.85%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-0.47%
|
O:
2.1%
H:
0.0%
C:
-2.52%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-2.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
-0.85%
|
O:
-0.1%
H:
0.13%
C:
-1.08%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
2.16%
|
O:
0.32%
H:
0.96%
C:
0.22%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.9%
|
O:
-2.13%
H:
0.0%
C:
0.0%
BMRN
|
$88.68
-1.54%
-1.57%
1.8M
|
Health Technology
|
-0.46%
|
O:
-0.72%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-0.68%
|
O:
-0.64%
H:
0.45%
C:
-0.04%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.22%
|
O:
0.41%
H:
0.0%
C:
0.0%
set
therapeutics
market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published:
2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.01%
|
O:
2.24%
H:
0.0%
C:
-0.8%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.57%
|
O:
-3.43%
H:
6.21%
C:
6.21%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-5.76%
|
O:
-0.25%
H:
1.1%
C:
-0.17%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.83%
|
O:
-0.05%
H:
0.43%
C:
-0.27%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-5.88%
|
O:
-0.08%
H:
0.04%
C:
-0.35%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-16.04%
|
O:
0.38%
H:
0.0%
C:
-7.27%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-1.64%
|
O:
0.77%
H:
1.63%
C:
0.35%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.02%
|
O:
0.84%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.21%
|
O:
0.18%
H:
0.3%
C:
0.19%
eczema
dermatitis
set
therapeutics
market
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-03-27
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.02%
|
O:
-1.17%
H:
0.0%
C:
-0.89%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
0.45%
|
O:
0.89%
H:
0.78%
C:
0.78%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-7.89%
|
O:
0.02%
H:
0.51%
C:
-0.3%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-9.3%
|
O:
0.26%
H:
2.03%
C:
1.57%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.42%
|
O:
0.36%
H:
0.72%
C:
0.61%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.06%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-8.47%
|
O:
-0.96%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.01%
|
O:
-0.12%
H:
0.25%
C:
-0.63%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.46%
|
O:
0.54%
H:
0.0%
C:
0.0%
abbvie
set
canada
key
market
Global OTC Artificial Tears Analysis Report 2023-2030: The Influence of Smart Technologies, Market Positioned for Continued Expansion Amid Growing Focus on Eye Wellness
Published:
2024-03-21
(Crawled : 00:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-3.12%
|
O:
0.17%
H:
0.28%
C:
-0.01%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.81%
|
O:
0.02%
H:
0.0%
C:
0.0%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-8.0%
|
O:
-0.74%
H:
1.54%
C:
1.38%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.49%
|
O:
0.16%
H:
0.0%
C:
0.0%
report
expansion
global
wellness
smart
growing
eye
market
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published:
2024-03-15
(Crawled : 14:30)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.3%
|
O:
0.21%
H:
0.97%
C:
0.7%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.15%
|
O:
0.05%
H:
0.14%
C:
-0.93%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.85%
|
O:
-1.58%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-1.31%
|
O:
-0.7%
H:
0.73%
C:
-0.16%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.4%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.03%
|
O:
-0.02%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-6.03%
|
O:
-0.27%
H:
1.26%
C:
0.84%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.43%
|
O:
0.2%
H:
1.14%
C:
-1.18%
antibody
therapeutics
market
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published:
2024-03-13
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.76%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.71%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-10.2%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-0.55%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.97%
|
O:
0.59%
H:
0.01%
C:
-1.45%
drug
disease
report
research
global
market
Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published:
2024-03-13
(Crawled : 01:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.76%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.71%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-10.2%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-0.55%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.97%
|
O:
0.59%
H:
0.01%
C:
-1.45%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.85%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
research
global
Biologics Contract Development And Manufacturing Organization (CDMO) Market to grow by USD 10.63 billion, The availability of cost-efficient resources to boost market growth, Technavio
Published:
2024-03-12
(Crawled : 05:00)
- prnewswire.com
GIKLY
|
$4.58
132.75%
820
|
Manufacturing
|
0.22%
|
O:
-4.79%
H:
0.0%
C:
-0.23%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-5.17%
|
O:
2.2%
H:
0.0%
C:
-2.57%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.18%
|
O:
-1.55%
H:
0.23%
C:
-0.03%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.02%
|
O:
1.04%
H:
0.0%
C:
0.0%
contract
market
Janus Kinase (JAK) Inhibitors Global Market Report 2024, Featuring Key Players Pfizer, Merck, AbbVie, Novartis, Sanofi, Bristol Myers Squibb, GSK, Takeda, Eli Lilly and Gilead Sciences
Published:
2024-03-05
(Crawled : 01:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.72%
|
O:
0.32%
H:
0.22%
C:
-0.2%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-7.56%
|
O:
-0.24%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.17%
|
O:
1.17%
H:
0.0%
C:
0.0%
report
sciences
global
key
market
Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging Population Fostering Growth
Published:
2024-02-28
(Crawled : 11:00)
- prnewswire.com
ROIV
|
$10.46
0.97%
0.96%
4.7M
|
Manufacturing
|
-11.53%
|
O:
-0.76%
H:
0.51%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.76%
|
O:
0.05%
H:
0.06%
C:
-0.95%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.41%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-7.61%
|
O:
0.6%
H:
0.02%
C:
-1.03%
global
set
dermatological
advanced
growth
market
United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published:
2024-02-22
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.97%
|
O:
0.37%
H:
0.58%
C:
0.58%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.46%
|
O:
0.89%
H:
0.4%
C:
0.17%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.45%
|
O:
0.57%
H:
0.47%
C:
-0.58%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-5.9%
|
O:
0.14%
H:
1.01%
C:
0.51%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.56%
|
O:
0.29%
H:
0.93%
C:
0.47%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.02%
|
O:
0.97%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-8.08%
|
O:
0.65%
H:
1.35%
C:
0.41%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.1%
|
O:
0.47%
H:
2.0%
C:
0.93%
pharmaceuticals
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-5.87%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
6.54%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.14%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
25.87%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-16.01%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.79%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.24%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-5.58%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
0.65%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-5.13%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.33%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.44%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.88%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-6.54%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published:
2024-02-15
(Crawled : 23:00)
- prnewswire.com
TRUMF
|
$16.928
-17.59%
1.9K
|
Health Technology
|
-53.57%
|
O:
0.79%
H:
0.0%
C:
-3.21%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.42%
|
O:
1.66%
H:
0.0%
C:
-1.59%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-5.89%
|
O:
1.66%
H:
0.0%
C:
-1.04%
TRUMY
|
$16.507
0.79%
34K
|
Manufacturing
|
-55.13%
|
O:
0.27%
H:
0.0%
C:
-2.6%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.57%
|
O:
0.37%
H:
0.57%
C:
0.19%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.21%
|
O:
-0.83%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.47%
|
O:
0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.15%
|
O:
-0.6%
H:
0.0%
C:
0.0%
drug
patent
report
review
global
advanced
market
Global Biosimilar Monoclonal Antibodies Market Report 2024: Future Market Growth Powered by Biologics and Personalized Therapy Advances
Published:
2024-02-14
(Crawled : 20:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.06%
|
O:
1.95%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.03%
|
O:
0.26%
H:
0.87%
C:
0.32%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-4.64%
|
O:
0.48%
H:
1.56%
C:
1.48%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-8.67%
|
O:
-0.75%
H:
0.86%
C:
0.41%
biosimilar
report
global
therapy
growth
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
12.13%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-13.68%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.11%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-7.41%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.44%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-3.58%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
1.83%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-2.91%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-4.57%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$14.08
-0.99%
-0.99%
470K
|
Health Technology
|
-25.59%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.63%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.49%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-8.91%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-8.68%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-20.26%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
11.16%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$360.11
0.47%
0.47%
330K
|
Health Technology
|
-5.61%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-10.02%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published:
2024-02-12
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
9.56%
|
O:
-0.57%
H:
0.04%
C:
-1.74%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-7.87%
|
O:
-1.46%
H:
1.04%
C:
0.97%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
1.43%
|
O:
0.09%
H:
0.0%
C:
-0.48%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-3.03%
|
O:
0.02%
H:
0.46%
C:
-0.14%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.62%
|
O:
-0.83%
H:
0.7%
C:
-0.27%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.21%
|
O:
-0.64%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.34%
|
O:
-0.86%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
9.65%
|
O:
-1.77%
H:
0.46%
C:
0.41%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-8.99%
|
O:
-0.4%
H:
1.6%
C:
1.54%
report
health
treatment
care
global
market
Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published:
2024-02-09
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-12.38%
|
O:
-0.91%
H:
3.88%
C:
3.88%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
8.24%
|
O:
-2.6%
H:
2.26%
C:
1.44%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-9.35%
|
O:
-2.46%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-12.95%
|
O:
4.66%
H:
0.0%
C:
-3.92%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-7.8%
|
O:
-0.04%
H:
0.11%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.17%
|
O:
-0.37%
H:
0.21%
C:
0.05%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.31%
|
O:
0.33%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.26%
|
O:
1.11%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
7.47%
|
O:
-1.28%
H:
1.05%
C:
-0.72%
research
global
market
Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published:
2024-02-07
(Crawled : 08:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.09%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.98%
|
O:
0.41%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-10.28%
|
O:
0.09%
H:
0.39%
C:
-0.36%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-5.15%
|
O:
0.43%
H:
0.67%
C:
0.21%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
-0.03%
|
O:
0.21%
H:
0.24%
C:
-1.04%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-3.43%
|
O:
1.48%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.19%
|
O:
1.33%
H:
0.0%
C:
0.0%
BMRN
|
$88.68
-1.54%
-1.57%
1.8M
|
Health Technology
|
1.44%
|
O:
-0.38%
H:
1.79%
C:
0.22%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.83%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-16.18%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
america
therapeutics
growth
market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-13.72%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.09%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.98%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
37.02%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-14.23%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.13%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-10.28%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.93%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
6.49%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-1.95%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-3.43%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.09%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.19%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
-14.12%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.83%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-16.18%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
← Previous
1
2
3
4
5
6
7
8
9
10
11
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.